1. Levey, A.S., Coresh, J.: Chronic kidney disease. Lancet 379, 165–180 (2012)
2. Chronic Kidney Disease Platform,
http://gid.min-saude.pt/irc.php?lang=en
3. Hemmelgarn, B.R., Manns, B.J., Lloyd, A., James, M.T., Klarenbach, S., Quin, R.R., Wiebe, N., Tonelli, M.: for the Alberta Kidney Disease Network: Relation between kidney function, proteinuria, and adverse outcomes. Journal of American Medical Association 303, 423–429 (2010)
4. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group: KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease. Kidney International Supplements 3, 1–150 (2013)
5. Lipid modification: cardiovascular risk assessment and the modification of blood lipids for the primary and secondary prevention of cardiovascular disease. NICE clinical guideline 181, National Institute for Health and Care Excellence (2014),
http://www.nice.org.uk/guidance/cg181/resources/guidance-lipid-modification-cardiovascular-risk-assessment-and-the-modification-of-blood-lipids-for-the-primary-and-secondary-prevention-of-cardiovascular-disease-pdf